Cover Image

Reply to Garnemark et al. The Swedish National Formulary for Children ePed. Comment on "Shaniv et al. A Callout for International Collaboration. Reply to Giger, E.V.; Tilen, R. Comment on "Shaniv et al. Neonatal Drug Formularies-A Global Scope. <i>Children</i> 2023, <i>10</i>, 848". <i>Children</i> 2023, <i>10</i>, 1803"

We received the comment from our Swedish colleagues and have read it with interest [...]

Saved in:

Bibliographic Details
Main Authors:	Dotan Shaniv (Author), Anne Smits (Author), Karel Allegaert (Author), on behalf of the Neonatal Drug Formularies Group (Author)
Format:	Book
Published:	MDPI AG, 2024-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A Callout for International Collaboration. Reply to Giger, E.V.; Tilen, R. Comment on "Shaniv et al. Neonatal Drug Formularies-A Global Scope. <i>Children</i> 2023, <i>10</i>, 848"
by: Dotan Shaniv, et al.
Published: (2023)

The Swedish National Formulary for Children ePed. Comment on Shaniv et al. A Callout for International Collaboration. Reply to Giger, E.V.; Tilen, R. Comment on "Shaniv et al. Neonatal Drug Formularies-A Global Scope. <i>Children</i> 2023, <i>10</i>, 848". <i>Children</i> 2023, <i>10</i>, 1803
by: Christiane A. Garnemark, et al.
Published: (2024)

Comment on Shaniv et al. Neonatal Drug Formularies-A Global Scope. <i>Children</i> 2023, <i>10</i>, 848
by: Elisabeth V. Giger, et al.
Published: (2023)

Reply to Hall et al. Comment on "Dinesen et al. Diphoterine for Chemical Burns of the Skin: A Systematic Review. <i>Eur. Burn J.</i> 2023, <i>4</i>, 55-68"
by: Felicia Dinesen, et al.
Published: (2023)

Reply to Herrmann et al. Comment on "van Gemert et al. Asymptomatic Infant Rib Fractures Are Primarily Non-abuse-Related and Should Not Be Used to Assess Physical Child Abuse. <i>Children</i> 2023, <i>10</i>, 1827"
by: Martin J. C. van Gemert, et al.
Published: (2024)

Reply to Gijon-Nogueron, G. Comment on "Alfageme-Garcia et al. Respectful Children's Shoes: A Systematic Review. <i>Children</i> 2024, <i>11</i>, 761"
by: Pilar Alfageme-García, et al.
Published: (2024)

Reply to "Comment on López-Yerena et al. 'Absorption and Intestinal Metabolic Profile of Oleocanthal in Rats' <i>Pharmaceutics</i> 2020, <i>12</i>, 134"
by: Anallely López-Yerena, et al.
Published: (2020)

Reply to "Comment on Casiraghi et al. 'Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis' 2020, <i>12</i>, 211"
by: Antonella Casiraghi, et al.
Published: (2020)

Reply to Peña, A. Comment on "Küppers et al. Percutaneous Anorectoplasty (PARP)-An Adaptable, Minimal-Invasive Technique for Anorectal Malformation Repair. <i>Children</i> 2022, <i>9</i>, 587"
by: Julia Küppers, et al.
Published: (2022)

Reply to Kersting et al. Comment on "Wunsch et al. The Impact of COVID-19 on the Interrelation of Physical Activity, Screen Time and Health-Related Quality of Life in Children and Adolescents in Germany: Results of the Motorik-Modul Study. <i>Children</i> 2021, <i>8</i>, 98"
by: Kathrin Wunsch, et al.
Published: (2021)

Reply to Papini, A. Comment on "Nekkaa et al. <i>Rhamnus alaternus</i> Plant: Extraction of Bioactive Fractions and Evaluation of Their Pharmacological and Phytochemical Properties. <i>Antioxidants</i> 2021, <i>10</i>, 300"
by: Amine Nekkaa, et al.
Published: (2023)

Comment on Alfageme-Garcia et al. Respectful Children's Shoes: A Systematic Review. <i>Children</i> 2024, <i>11</i>, 761
by: Gabriel Gijon-Nogueron
Published: (2024)

Comment on Dinesen et al. Diphoterine for Chemical Burns of the Skin: A Systematic Review. <i>Eur. Burn J.</i> 2023, <i>4</i>, 55-68
by: Alan Hall, et al.
Published: (2023)

Reply to Maase et al. Comment on "Jones et al. Application of a Novel Algorithm for Expanding Newborn Screening for Inherited Metabolic Disorders across Europe. <i>Int. J. Neonatal Screen.</i> 2022, <i>8</i>, 20"
by: Simon A. Jones, et al.
Published: (2023)

Comment on van Gemert et al. Asymptomatic Infant Rib Fractures Are Primarily Non-abuse-Related and Should Not Be Used to Assess Physical Child Abuse. <i>Children</i> 2023, <i>10</i>, 1827
by: Bernd Herrmann, et al.
Published: (2024)

Reply to "Comment on Ahmad, I.M. et al. Healthcare Workers Occupationally Exposed to Ionizing Radiation Exhibit Altered Levels of Inflammatory Cytokines and Redox Parameters. <i>Antioxidants</i>, 2019, <i>8</i>, 12"
by: Iman M. Ahmad
Published: (2019)

Reply to the comments by Falsetti et al.
by: T. Suzuki, et al.
Published: (2020)

Reply to Mrakic-Sposta et al. Comment on "Menzel et al. Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice-Which to Use Regarding Disease Outcomes? <i>Antioxidants</i> 2021, <i>10</i>, 414"
by: Alain Menzel, et al.
Published: (2021)

Correction: Tran et al. Antimicrobial Properties of <i>Bacillus</i> Probiotics as Animal Growth Promoters. <i>Antibiotics</i> 2023, <i>12</i>, 407
by: Charlie Tran, et al.
Published: (2023)

Correction: Al-Ahmad et al. Biodentine Inhibits the Initial Microbial Adhesion of Oral Microbiota In Vivo. <i>Antibiotics</i> 2023, <i>12</i>, 4
by: Ali Al-Ahmad, et al.
Published: (2024)

Correction: Volkova et al. Cyclodextrin's Effect on Permeability and Partition of Nortriptyline Hydrochloride. <i>Pharmaceuticals</i> 2023, <i>16</i>, 1022
by: Tatyana Volkova, et al.
Published: (2023)

Correction: Amin et al. Evaluation of Medication Prescribing Applications Available in Australia. <i>Pharmacy</i> 2023, <i>11</i>, 49
by: Riya Amin, et al.
Published: (2023)

Correction: Alhasso et al. Development of a Nanoemulgel for the Topical Application of Mupirocin. <i>Pharmaceutics</i> 2023, <i>15</i>, 2387
by: Bahjat Alhasso, et al.
Published: (2024)

Correction: Singh et al. Nanotechnology-Aided Advancement in Combating the Cancer Metastasis. <i>Pharmaceuticals</i> 2023, <i>16</i>, 899
by: Arun Kumar Singh, et al.
Published: (2024)

Comment on Küppers et al. Percutaneous Anorectoplasty (PARP)-An Adaptable, Minimal-Invasive Technique for Anorectal Malformation Repair. <i>Children</i> 2022, <i>9</i>, 587
by: Alberto Peña
Published: (2022)

Correction: Leppäniemi et al. Nutrition Profile for Countries of the Eastern Mediterranean Region with Different Income Levels: An Analytical Review. <i>Children</i> 2023, <i>10</i>, 236
by: Hanna Leppäniemi, et al.
Published: (2024)

Correction: Nerdrum Aagaard et al. Significance of Neonatal Heart Rate in the Delivery Room-A Review. <i>Children</i> <b>2023</b>, <i>10</i>, 1551
by: Ellisiv Nerdrum Aagaard, et al.
Published: (2024)

Correction: Szymanowicz et al. Headache and <i>NOTCH3</i> Gene Variants in Patients with CADASIL. <i>Neurol. Int.</i> 2023, <i>15</i>, 1238-1252
by: Oliwia Szymanowicz, et al.
Published: (2024)

Comment on López-Yerena et al. "Absorption and Intestinal Metabolic Profile of Oleocanthal in Rats" <i>Pharmaceutics</i> 2020, <i>12</i>, 134
by: Amal Kaddoumi, et al.
Published: (2020)

RETRACTED: Wiesinger et al. An Innovative Tool for Evidence-Based, Personalized Treatment Trials in Mucopolysaccharidosis. <i>Pharmaceutics</i> 2023, <i>15</i>, 1565
by: Anna-Maria Wiesinger, et al.
Published: (2023)

Reply to Frański, R.; Beszterda-Buszczak, M. Comment on "Villalva et al. Antioxidant, Anti-Inflammatory, and Antibacterial Properties of an <i>Achillea millefolium</i> L. Extract and Its Fractions Obtained by Supercritical Anti-Solvent Fractionation against <i>Helicobacter pylori</i>. <i>Antioxidants</i> 2022, <i>11</i>, 1849"
by: Marisol Villalva, et al.
Published: (2023)

Reply to Torlakovic, E.; Normanno, N. Comment on "Bisson et al. Novel Approach to Proficiency Testing Highlights Key Practice Variations in Cancer Biomarker Delivery. <i>J. Mol. Pathol.</i> 2024, <i>5</i>, 1-10"
by: Brandon S. Sheffield, et al.
Published: (2024)

Comment on Nekkaa et al. <i>Rhamnus alaternus</i> Plant: Extraction of Bioactive Fractions and Evaluation of Their Pharmacological and Phytochemical Properties. <i>Antioxidants</i> 2021, <i>10</i>, 300
by: Alessio Papini
Published: (2023)

Correction: Chen et al. Bromelain Ameliorates Atherosclerosis by Activating the TFEB-Mediated Autophagy and Antioxidant Pathways. <i>Antioxidants</i> 2023, <i>12</i>, 72
by: Chia-Hui Chen, et al.
Published: (2024)

Comment on Casiraghi et al. "Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis" 2020, <i>12</i>, 211
by: Eyal Zur
Published: (2020)

Correction: Furugaito et al. Antimicrobial Susceptibility to 27 Drugs and the Molecular Mechanisms of Macrolide, Tetracycline, and Quinolone Resistance in <i>Gemella</i> sp. <i>Antibiotics</i> 2023, <i>12</i>, 1538
by: Michiko Furugaito, et al.
Published: (2024)

Correction: Lungu et al. Molecular Characterisation of Antimicrobial Resistance in <i>E. coli</i> Isolates from Piglets in the West Region of Romania. <i>Antibiotics</i> 2023, <i>12</i>, 1544
by: Bianca Cornelia Lungu, et al.
Published: (2024)

Correction: Joseph et al. Efficacy of Ketamine with and without Lamotrigine in Treatment-Resistant Depression: A Preliminary Report. <i>Pharmaceuticals</i> 2023, <i>16</i>, 1164
by: Boney Joseph, et al.
Published: (2023)

Reply to a Comment Paper on the Published Paper by Canta, A. et al: "Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced Peripheral Neurotoxicity"-<i>Antioxidants</i> 2020, <i>9</i>, 594
by: Annalisa Canta, et al.
Published: (2020)

Reply to Zandi, M.; Soltani, S. Comment on "Alfassam et al. Development of a Colorimetric Tool for SARS-CoV-2 and Other Respiratory Viruses Detection Using Sialic Acid Fabricated Gold Nanoparticles. <i>Pharmaceutics</i> 2021, <i>13</i>, 502"
by: Haya A. Alfassam, et al.
Published: (2022)